Thomas Steyer Farallon Capital Management
Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$209M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$193M |
| 3 |
Howmet Aerospace
HWM
|
+$184M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$172M |
| 5 |
T-Mobile US
TMUS
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.42B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$476M |
| 3 |
Willis Towers Watson
WTW
|
+$468M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$462M |
| 5 |
Aon
AON
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.83% |
| 2 | Technology | 13.3% |
| 3 | Industrials | 11.55% |
| 4 | Communication Services | 11.47% |
| 5 | Financials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $1.61B | 7.52% |
3,756,000
-1,490,000
| -28% | -$657M |
|
|
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $1.16B | 5.41% |
2,700,000
-810,000
| -23% | -$357M |
|
3
IQVIA
IQV
$42.8B
| $648M | 3.02% |
2,703,756
-163,080
| -6% | -$41.2M |
|
4
Boston Scientific
BSX
$73B
| $608M | 2.84% |
14,002,581
+1,285,962
| +10% | +$56.9M |
|
|
5
Aramark
ARMK
$15.8B
| $602M | 2.81% |
25,369,954
+8,457,788
| +50% | +$209M |
|
|
6
T-Mobile US
TMUS
$196B
| $588M | 2.74% |
4,599,011
+1,150,530
| +33% | +$160M |
|
7
Thermo Fisher Scientific
TMO
$233B
| $560M | 2.61% |
979,659
-364,419
| -27% | -$200M |
|
|
NUAN
8
DELISTED
Nuance Communications, Inc.
NUAN
| $515M | 2.4% |
9,360,000
+2,022,500
| +28% | +$111M |
|
9
Wabtec
WAB
$50.3B
| $513M | 2.39% |
5,945,151
+670,300
| +13% | +$57.7M |
|
10
Alphabet (Google) Class C
GOOG
$4.18T
| $481M | 2.24% |
3,609,140
-649,200
| -15% | -$89.5M |
|
|
XLNX
11
DELISTED
Xilinx Inc
XLNX
| $470M | 2.19% |
3,112,800
-993,200
| -24% | -$146M |
|
12
RTX Corp
RTX
$283B
| $448M | 2.09% |
5,214,986
+465,000
| +10% | +$39.8M |
|
13
Salesforce
CRM
$171B
| $428M | 2% |
1,577,915
+100,300
| +7% | +$25.5M |
|
14
Microsoft
MSFT
$3.59T
| $426M | 1.99% |
1,512,578
-200,500
| -12% | -$58.3M |
|
15
New York Times
NYT
$10.6B
| $401M | 1.87% |
8,136,258
+1,521,000
| +23% | +$72M |
|
|
XLRN
16
DELISTED
Acceleron Pharma
XLRN
| $373M | 1.74% |
2,164,663
-335,337
| -13% | -$43.9M |
|
17
Meta Platforms (Facebook)
META
$1.4T
| $362M | 1.69% |
1,065,745
-160,800
| -13% | -$57.9M |
|
|
18
Aon
AON
$75.3B
| $361M | 1.68% |
1,262,315
-1,380,299
| -52% | -$371M |
|
19
Mastercard
MA
$509B
| $330M | 1.54% |
948,100
+20,500
| +2% | +$7.45M |
|
|
20
Howmet Aerospace
HWM
$108B
| $325M | 1.52% |
10,408,000
+5,705,521
| +121% | +$184M |
|
|
BBL
21
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $322M | 1.5% |
6,354,000
+154,000
| +2% | +$9.26M |
|
|
22
Willis Towers Watson
WTW
$31.8B
| $319M | 1.49% |
1,373,000
-2,101,660
| -60% | -$468M |
|
|
KSU
23
DELISTED
Kansas City Southern
KSU
| $319M | 1.49% |
1,179,032
+693,032
| +143% | +$193M |
|
24
Elevance Health
ELV
$86.9B
| $319M | 1.49% |
854,965
+204,965
| +32% | +$77.9M |
|
25
Broadcom
AVGO
$1.75T
| $315M | 1.47% |
6,505,000
-839,000
| -11% | -$40.8M |
|
Similar funds
Thomas Steyer's Q3 2021 Portfolio in Review
As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.
Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.
- Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
- Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
- Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
- Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
- Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
- Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
- Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.
Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.